The need for a correct oxygen-ozone autohemotherapy (O3-AHT) in patients with mild to moderate COVID-19 pneumonia
- PMID: 33400161
- PMCID: PMC7782567
- DOI: 10.1007/s11739-020-02592-w
The need for a correct oxygen-ozone autohemotherapy (O3-AHT) in patients with mild to moderate COVID-19 pneumonia
Conflict of interest statement
The Authors state they have no conflict of interest.
Comment in
-
Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience: reply.Intern Emerg Med. 2021 Apr;16(3):795-796. doi: 10.1007/s11739-021-02630-1. Epub 2021 Feb 3. Intern Emerg Med. 2021. PMID: 33534080 Free PMC article. No abstract available.
Comment on
-
Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience.Intern Emerg Med. 2021 Apr;16(3):669-675. doi: 10.1007/s11739-020-02542-6. Epub 2020 Nov 1. Intern Emerg Med. 2021. PMID: 33131033 Free PMC article.
References
-
- Tascini C, Sermann G, Pagotto A, Sozio E, De Carlo C, Giacinta A, Sbrana F, Ripoli A, Castaldo N, Merelli M, Cadeo B, Macor C, De Monte A. Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience. Intern Emerg Med. 2020 doi: 10.1007/s11739-020-02542-6. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical